Msa Safety Inc (MSA) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Msa Safety Inc  (NYSE: MSA)


Msa Safety Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Msa Safety Inc's ROA in the second quarter of 2026?
Msa Safety Inc achieved a return on average assets (ROA) of 12.2 % in its second quarter of 2026, this is above MSA's average return on assets of 6.75%.
Msa Safety Incs assets during the 12 months ending in the second quarter of 2026 are valued at $2 billion

ROA has improved compared to 11.35% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 78 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 538, from total ROA ranking in the first quarter of 2026 at 613.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 2.01 % 14.67 % 16.82 % 13.9 % 13.67 %
Y / Y Net Income Change 37.31 % 19.57 % -1.15 % 4.45 % -13.1 %
Net Income (TTM) in million 314 291 279 280 277
Return On Assets (TTM) 12.2 % 11.35 % 11.25 % 11.73 % 12 %
MSA's Total Ranking # 538 # 613 # 509 # 476 # 435
Total Assets (TTM) in million 2,602 2,564 2,577 2,554 2,550
Seq. Total Assets Change 1.46 % -0.5 % 0.91 % 0.13 % 14.06 %
Seq. Net Income Change 20.94 % -18.02 % 24.88 % 10.9 % 5.31 %



Return On Assets Company Ranking
Within: No.
Industry # 19
Sector # 79
Overall # 476

Return On Assets Statistics
High Average Low
12.86 %
6.75 %
-0.26 %
(Dec 31 2024)   (Mar 31 2023)





Financial Statements
Msa Safety Inc's Assets $ 2,602 million MSA's Balance sheet
Msa Safety Inc's Income $ 86 million Quarterly MSA's Income Statement
MSA's Income by Division See MSA's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 15.8 % 1.64 % -7.29 % -0.28 % 30.59 %
Total Assets in million 2,554 2,206 2,170 2,341 2,347
Y / Y Net Income Change -2.12 % 386.43 % -67.39 % 724.44 % -82.02 %
Net Income in million 279 285 59 180 22
Annual Return On Assets 10.92 % 12.92 % 2.7 % 7.67 % 0.93 %




Comment on MSA's ROA in the fiscal year ending 2025
In the fiscal year 2025 Msa Safety Inc's ROA decreased compared to previous year to 10.92 %, due to deterioration of net income -2.12 % to $278.92 million, from $284.97 million a year ago, as MSA's assets were $2,554.37 million.


More Return On Assets Ratios
MSA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MSA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MSA's Competitors
Subscribers only: Roa for Msa Safety Inc's Suppliers
Subscribers only: Return On Assets for MSA's Customers

You may also want to know
MSA's Roi MSA's Inventory Turnover Ratio MSA's Growth Rates MSA's Dividend Comparisons
MSA's Profitability Ratios MSA's Asset Turnover Ratio MSA's Dividend Growth
MSA's Roe MSA's Valuation Ratios MSA's Financial Strength Ratios MSA's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %
Inspire Medical Systems inc   15.21 %
Dexcom Inc   14.87 %
Neurocrine Biosciences Inc   14.73 %
Entera Bio Ltd   14.60 %


Date modified: 2026-09-05T06:59:34+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.